After more than a year of committing scientific fraud to push false “positives” via PCR testing, the CDC has announced it is withdrawing the RT-PCR Diagnostic Panel on December 31st of this year
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
The use of PCR tests for covid illness diagnosis is a global scientific fraud, since no PCR instrument can produce quantitative results that might indicate a specific viral load. Yet this CDC-approved testing protocol was relied on to fabricate the “casedemic” illusion which pretended that hundreds of millions of people around the world were infected with covid.newstarget CDC withdraws fraudulent PCR testing protocol that was used to falsify covid “positives” to push the plandemic